Genesis Cancer Care Institute
Davenport, Iowa, United States
Cancer treatment center in Davenport, Iowa
1401 W Central Park Ave 1st Floor, Davenport, IA 52804
About Genesis Cancer Care Institute
"The Genesis Cancer Care Institute helps patients beat cancer by using the next generation of cancer-fighting technology, combined with a focus on resources and support for the patient and family."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
22
Alliance for Clinical Trials in Oncology
7
SWOG Cancer Research Network
7
ECOG-ACRIN Cancer Research Group
3
NRG Oncology
2
GOG Foundation
1
Clinical Trials at Genesis Cancer Care Institute
During the past decade, Genesis Cancer Care Institute conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 13 clinical trials were completed, i.e. on
average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
2006-09-15
2014-07-02
Completed
295
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Genesis Cancer Care Institute" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials
sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology"
with 3 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Cancer Care Institute"
#1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Genesis Cancer Care Institute
According to Clinical.Site data, the most researched conditions in "Genesis Cancer Care Institute" are
"Invasive Breast Carcinoma" (5 trials), "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IVA Lung Cancer AJCC v8" (5 trials), "Stage IVB Lung Cancer AJCC v8" (5 trials) and "Estrogen Receptor Negative" (4 trials). Many other conditions were trialed in "Genesis Cancer Care Institute" in a lesser frequency.
Clinical Trials Intervention Types at Genesis Cancer Care Institute
Most popular intervention types in "Genesis Cancer Care Institute" are "Drug" (34 trials), "Other" (28 trials), "Biological" (18 trials), "Procedure" (10 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (13 trials), "Biospecimen Collection" (8 trials), "Cisplatin" (8 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.
Clinical Trials Genders at Genesis Cancer Care Institute
The vast majority of trials in "Genesis Cancer Care Institute" are
36 trials for "All" genders and 6 trials for "Female" genders.
Clinical Trials Status at Genesis Cancer Care Institute
Currently, there are NaN active trials in "Genesis Cancer Care Institute".
undefined are not yet recruiting,
12 are recruiting,
22 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Genesis Cancer Care Institute,
1 suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Genesis Cancer Care Institute, 0 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".